14 articles for A Mukherjee
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
34
G9a/GLP Modulators: Inhibitors to Degraders.

Osaka University
1
Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches.

Baylor College of Medicine
25
Evolution of Slow-Binding Inhibitors Targeting Histone Deacetylase Isoforms.

Osaka University
61
Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.

Csir-Indian Institute of Chemical Biology
5
Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.

Kyoto Prefectural University of Medicine
30
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9.

Csir-Indian Institute of Chemical Biology
3
Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.

The University of Tennessee Health Science Center
12
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist.

Csir-Indian Institute of Chemical Biology
27
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.

Csir-Indian Institute of Chemical Biology
34
Activity-guided development of potent and selective toll-like receptor 9 antagonists.

Csir-Indian Institute of Chemical Biology
8
A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.

Jadavpur University
17
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism.

Csir-Indian Institute of Chemical Biology
47
Neprilysin inhibitors

Theravance Biopharma R&D Ip
459
Piperidinylpyrazolopyrimidinones and their use

Bayer